TL;DR
- The execution layer in clinical trials is fragmented, hindering AI's potential
- AI's ability to deliver results is compromised by the lack of a robust infrastructure
Summary
The clinical trial landscape has made significant strides in data capture, but the underlying infrastructure remains a bottleneck. The execution layer, comprising decision workflows, data collection design, and lab connectivity, is fragmented, limiting the potential of AI in clinical trials. This gap must be addressed to ensure the scientific validity of the data and unlock AI's full potential. A robust infrastructure is essential for AI to deliver meaningful results and drive breakthroughs in medical research.
Content
The clinical trial ecosystem has undergone a transformation in data capture, with advancements in technology and process improvements. However, the execution layer, which includes decision workflows, data collection design, and lab connectivity, remains a critical challenge. This layer is the backbone of clinical trials, and its fragmentation has a ripple effect on the entire process. According to the original piece, the execution gap has been a long-standing issue, with the original reporting details highlighting the limitations of current infrastructure. The lack of a robust infrastructure compromises the scientific validity of the data, making it challenging for AI to deliver meaningful results. The original piece emphasizes that AI's potential is quietly compromised by the execution gap, and it is essential to address this issue to unlock AI's full potential in clinical trials. The reporting details also suggest that the execution gap is not just a technical issue but also a strategic one, requiring a concerted effort from stakeholders to build a robust infrastructure. The original piece concludes that the execution gap must be closed before AI can deliver on its promise, and it is imperative to prioritize this issue to drive breakthroughs in medical research.
ICYMI
- The execution gap is a long-standing issue in clinical trials, with the original reporting details highlighting its limitations
- The lack of a robust infrastructure compromises the scientific validity of the data and hinders AI's ability to deliver results
Original Post is from: appliedclinicaltrialsonline.com
Read it here
See this article here: